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1538Background: International Society of Heart and Lung Transplantation guidelines for adult heart transplantation
(HT) suggest a donor to recipient body weight ratio (WR) of greater than 0.8. For female to male transplants,
a WR of greater than 0.9 is recommended.
Methods: The United Network for Organ Sharing database was examined for adult HT from 1999 to 2011.
Controls with a WR of 0.9 or greater (normal donor to recipient weight ratio) were compared with patients
with a WR of 0.6 to 0.89 (WRL) and a WR of less than 0.59 (WRVL). The primary measured outcome was
survival.
Results: Of the 21,928 patients undergoing HT, 14,592 (66.6%) were performed with a normal donor to
recipient weight ratio, 7212 (32.9%) were performed with WRL, and 124 (0.6%) were performed with
WRVL. In male donor to male recipient, male donor to female recipient, and female donor to female recipient
HT, the use of WRL did not influence median survival (P ¼ .3621) and was not associated with increased
mortality (P ¼ .7273). In female donor to male recipient HT, WRL was associated with decreased median
survival (435 days, P ¼ .0241) and was associated with increased mortality (hazard ratio, 1.201; P ¼ .0383).
Conclusions: HT can be safely performed using WRL donors between sex-matched and male to female trans-
plants. However, in female to male transplants, WRL donors are associated with decreased survival. Although
clinical circumstances will guide decision making, consensus criteria may be revisited to liberalize the pool of
acceptable donors in an era of unprecedented donor shortage. (J Thorac Cardiovasc Surg 2013;146:1538-43)Heart transplantation (HT) continues to be the accepted ther-
apy for end-stage heart failure.Althoughmorbidity andmor-
tality continue to decrease, limited donor availability has led
to an increase in waiting list times and increases in waiting
list mortality.1 There have been increasing efforts at expand-
ing the donor pool by extending donor criteria. The use of
donor hearts once thought to be unsuitable for transplant
because of structural or functional deficits has shown to be
safe for certain patients.2-10 The use of older donors5,11-13
and organs with longer ischemic times has also helped
expand the donor pool.14-16 Sex-mismatched donors have
also been used, albeit with increased adverse events.17
A previous study has shown that undersized donors with
weight mismatch greater than 20% do not result in
increased mortality, except in recipients with elevated
pulmonary vascular resistances.18 However, data on the
use of underweight heart transplant are conflicting.18-20e Department of Surgery,a Temple University Hospital, and the School of
c Health,b Temple University, Philadelphia, Pa; and the Section of Cardiac
ry,c Department of Surgery, Yale School of Medicine, New Haven, Conn.
res: Authors have nothing to disclose with regard to commercial support.
d for publication Jan 23, 2013; revisions received May 19, 2013; accepted for
ation June 27, 2013; available ahead of print Aug 5, 2013.
for reprints: Abeel A. Mangi, MD, Center for Advanced Heart Failure,
anical Circulatory Support and Heart Transplantation, Yale University
l of Medicine, Boardman 204, 330 Cedar St, New Haven, CT 06520
il: abeel.mangi@yale.edu).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2013.06.028
The Journal of Thoracic and Cardiovascular SurInternational Society of Heart and Lung Transplantation
adult heart transplant donor guidelines caution the use of
donors to within 20% of the recipient’s body weight.
When female donors are considered for male recipients, a
10% weight mismatch limit is recommended. In this
study, we attempted to determine if this donor to recipient
body weight ratio criterion could be safely extended.21METHODS
Data Source
After Institutional Review Board approval, public files from the United
Network for Organ Sharing (UNOS) registry were reviewed for adult
patients receiving primary HT from 1998 to 2011. A total of 21,928
patients underwent orthotopic HT during this period. Of these, 7212
(32.9%) were performed with selected underweight donors with a donor
to recipient body weight of 60% to 80% (WRL). In addition, 124
(0.6%) were performed with a carefully selected donor to recipient body
weight ratio of less than 60% (WRVL). These 2 cohorts were compared
with 14,592 patients (66.6%) with ideally matched donors.
Statistical Analysis
P < .05 was considered to be statistically significant. All data
analyses were performed using SAS, version 9.2 (SAS Institute, Cary,
NC). Continuous variables are presented as mean  SD, and categorical
variables are reported as percentages of the total number of data points
available for that field. Analysis of variance, Student t test, and c2 test
were used to analyze continuous and categorical variables. Kaplan-Meier
methods with log-rank test and Cox proportional hazards regression were
used to analyze median survival and differences between groups. For
survival analysis, female donor to male recipient HT determined the
division into 2 cohorts, because they experienced different selection
criteria based on International Society of Heart and Lung Transplantationgery c December 2013
Abbreviations and Acronyms
CO ¼ cardiac output
HR ¼ hazard ratio
HT ¼ heart transplantation
UNOS ¼ United Network for Organ Sharing
WR ¼ weight ratio
WRC ¼ normal donor to recipient weight ratio
WRL ¼ donor to recipient body weight of 60% to
80%
WRVL¼ donor to recipient body weight ratio of less
than 60%
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these cohorts.
Individual propensity scores were calculated for both cohorts based on
generally accepted transplant criteria (ie, female to male transplants>0.9
and other transplants>0.8). The female tomale transplant cohort propensity
scoreswere based on the following factors: recipient age, donor age, ischemia
time, recipient cardiac output (CO) before transplantation, pulmonary
vascular resistance, days on status 1a, HLA mismatch, race mismatch, and
transplant year. The other cohort used the following factors to calculate pro-
pensity scores: recipient age, donor age, recipient sex, donor sex, ischemia
time, recipient CO before transplantation, pulmonary vascular resistance,
days on status 1a, HLA mismatch, race mismatch, and transplant year.
The propensity scores were used to determine 1:1 matching for the
Kaplan-Meier analyses. The weight mismatch groups were included in
the Cox proportional hazards model, stratified by propensity score
quartiles, along with all covariates that were statistically significant on
univariate survival analysis.
RESULTS
Recipient Characteristics
Recipient characteristics are shown in Table 1. Of the
21,928 patients undergoing HT, 14,592 (66.6%) were
performed with normal donor to recipient weight ratio
(WRC), 7212 (32.9%) were performed with selected
donors who had a low donor to recipient weight ratio
(WRL), and 124 (0.6%) were performed with carefully
selected donors who had a very low donor to recipient
weight ratio (WRVL). Coronary artery disease and dilated
cardiomyopathy were the most common indications for
HT in all groups. There was no difference in recipient age
(P ¼ .9729). WRC was less likely to be male (74.7%)
than WRL (80.3%) or WRVL (77.4%) (P<.0001). WRC
recipients were most likely to be Hispanic (7.5%) and
Asian (3%), whereas WRVL recipients were more likely
to be white (76.6%) and black (17.7%) (P < .0001).
WRC had the highest pulmonary vascular resistance
(PVR) (2.6 vs 2.4 for WRL and WRVL; P< .0001) and
the lowest CO (4.4 vs 4.7 vs 4.9 for WRC vs WRL vs
WRVL, respectively; P<.0001).
Donor Characteristics
Donor characteristics are shown in Table 1. WRC had a
lower donor age than WRVL, but it was greater thanThe Journal of Thoracic and CarWRL (32.3 vs 30.1 vs 35.4 years for WRC vs WRL vs
WRVL; P < .0001). WRC had the greatest mean body
mass index (27.8 vs 24.2 vs 20.6 kg/m2 for WRC vs WRL
vs WRVL, respectively; P<.0001). WRC was less likely
to be male than WRL, but more likely than WRVL
(70.4% vs 72.6% vs 67.7% for WRC vs WRL vs
WRVL, respectively; P<.0001). WRC was most likely to
be diabetic (2.8% vs 1.5% vs 1.6% for WRC vs WRL vs
WRVL, respectively; P<.0001).
Transplant Characteristics
Transplant characteristics are summarized in Table 1.
WRVL was most likely to have sex mismatch (30.7% vs
29.3% vs 25.3% for WRVL vs WRC vs WRL, respec-
tively; P< .0001) and the greatest ischemic time (3.3 vs
3.2 hours for WRVL vs WRC and WRL; P<.0001). The
2 groups were evenly matched regarding race mismatch,
total HLA mismatches, and length of stay.
Survival
Sex-matched (male to male, female to female) and male
to female heart transplant. There are 12,192 patients in
the WRC group, 6025 in the WRL group, and 99 in the
WRVL group. Kaplan-Meier analysis of the propensity-
matched data set for all other transplants is shown in
Figure 1. Median survivals of the entire cohort for the
WRC (3982 days) and WRL (4054 days) groups were not
significantly different (P ¼ .3621). This was true when
male to male HTs (3982 vs 4054 days for WRC vs WRL;
P ¼ .4049), female to female HTs (3802 vs 3770 days for
WRC vs WRL; P ¼ .9667), and male to female HTs
(3982 vs 4054 days for WRC vs WRL; P ¼ .4049) were
analyzed individually. Results of the multivariate survival
analysis stratified by propensity score quartiles are shown
in Table 2. There was no greater likelihood of mortality
when the WRL group (P ¼ .7273) and WRVL group
(P ¼ .7646) were compared with the WRC group.
Covariates associated with mortality include recipient
creatinine at transplantation (hazard ratio [HR], 1.1;
P<.0001), donor age (HR, 1.017; P<.0001), sex mismatch
(HR, 1.191; P ¼ .0183), race mismatch (HR, 1.124;
P ¼ .004), and ischemia time (HR, 1.077; P<.0001).
Female to male heart transplant. There are 2400 in the
WRC group, 1187 in the WRL group, and 25 in the
WRVL group. Kaplan-Meier analysis of the propensity-
matched data set for female to male HTs is shown in
Figure 2. The median survival for the WRC (3973 days)
and WRL (3538 days) was significantly different
(P ¼ .0241). Results of the Cox proportional hazards
analysis, stratified by propensity score quartiles, are shown
in Table 3. When compared with the WRC group, there was
a significant difference in effect on mortality for WRL (HR,
1.208; 95% confidence interval, 1.01-1.444; P ¼ .0383),
but not for WRVL (P ¼ .8484). Factors associated withdiovascular Surgery c Volume 146, Number 6 1539
TABLE 1. Summary of data set characteristics
WR control:>0.9
(n ¼ 14,592)
WR low:>¼0.6-<0.9
(n ¼ 7212)
WR very low:<0.6
(n ¼ 124) P value
Recipient demographics
Recipient age, y 52.0  12.6 52.0  11.6 52.0  11.0 .9729
Male recipient 10,802 (74.7) 5790 (80.3) 96 (77.4) <.0001
Recipient ethnicity <.0001
White 10,571 (72.4) 5434 (75.4) 95 (76.6)
Black 2349 (16.1) 1216 (16.9) 22 (17.7)
Hispanic 1091 (7.5) 422 (5.9) 6 (4.8)
Asian 433 (3.0) 74 (1.0) 0
Other 148 (1.0) 7 (0.59) 1 (0.81)
Recipient BMI 25.6  9.2 30.1  36.9 38.4  11.6 <.0001
Recipient diabetes 1754 (12.0) 1019 (14.2) 14 (11.3) <.0001
Cardiac output at transplant 4.4  1.5 4.7  1.6 4.9  1.4 <.0001
PVR at transplant 2.6  2.1 2.4  1.8 2.4  1.8 <.0001
Creatinine at transplant 1.4  0.9 1.4  0.8 1.5  0.8 .004
Ventilator at transplant 456 (3.1) 195 (2.7) 6 (4.8) .1107
ECMO at transplant 85 (0.58) 24 (0.33) 1 (0.81) .0437
Donor demographics
Donor age, y 36.7  12.5 35.0  12.9 35.4  16.6 .0009
Male donor 10,276 (70.4) 5238 (72.6) 84 (67.7) .0023
Donor ethnicity .0103
White 1766 (73.6) 926 (78.0) 18 (72.0)
Black 331 (13.8) 101 (8.5) 5 (20.0)
Hispanic 256 (10.8) 127 (10.7) 1 (4.0)
Asian 22 (0.92) 17 (1.4) 1 (4.0)
Other 22 (0.92) 16 (1.1) 0
Donor BMI 30.1  6.7 24.3  3.9 19.3  3.0 <.0001
Donor diabetes 111 (4.6) 28 (2.4) 0 .011
Transplantation characteristics
Ischemia time, h 3.2  1.0 3.3  1.1 3.0  1.0 .3543
Length of stay, d 20.7  24.2 22.2  30.1 41.8  71.4 .0627
HLA mismatch 4.6  1.04 4.6  1.0 4.7  1.2 .6191
Race mismatch 948 (39.5) 420 (35.4) 10 (40.0) .0567
Sex mismatch 4274 (29.3) 1822 (25.3) 38 (30.7) <.0001
Data are given as mean  SD or number (%). WR, Weight ratio; BMI, body mass index; PVR, pulmonary vascular resistance; ECMO, extracorporeal membrane oxygenation;
HLA, human leukocyte antigen.
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recipient creatinine level at transplantation (HR, 1.162;
P<.0001), and donor age (HR, 1.014; P ¼ .0001).
DISCUSSION
Although HT remains an effective treatment for
end-stage heart failure,1 a shortage of available organ
donors has led to high mortality for patients awaiting
HT.22,23 Numerous attempts to extend the selection
criteria for donors deemed suitable for transplant have
been met with mixed results.2-9,11,12,14-16,18,24,25 In this
study, we attempt to determine if International Society of
Heart and Lung Transplantation guidelines regarding
underweight HT donors could be extended.21
Extending the weight mismatch criteria for underweight
donor hearts has been examined in previous studies4,18-20;
however, there is lack of consensus regarding this issue.
Patel and colleagues18 studied the donor to recipient weight1540 The Journal of Thoracic and Cardiovascular Surratio using the UNOS database in an analysis that included
2078 patients with a donor to recipient body weight ratio of
less than 0.8. This study concluded that male to male,
female to female, and male to female HT, with low donor
to recipient weight ratio, was safe in certain populations.
Our study set out to determine if this criterion could be
extended to a donor to recipient body weight ratio of less
than 0.8. We determined that transplanting patients with a
donor to recipient body weight ratio of less than 0.8 is not
associated with increased mortality when transplanting
male donors to male recipients, female donors to female
recipients, and male donors to female recipients.
When transplanting female donor hearts to male
recipients, a donor to recipient body weight ratio of greater
than 0.9 is recommended by International Society of Heart
and Lung Transplantation guidelines. In this study, indepen-
dent analysis of female donors to male recipients with
a donor to recipient body weight ratio of less thangery c December 2013
FIGURE 1. Kaplan-Meier survival analysis of sex-matched and male-to-
female transplantations, comparing control (>0.9) with low-weight ratio
(0.6-0.9). A, All transplantations (male to male, female to female, and
male to female). B, Male-to-male transplantations. C, Female-to-female
transplantations. D, Male-to-female transplantations.
TABLE 2. Cox proportional hazards model for female-to-female HT,
male-to-male HT, and male-to-female HT
Predictors
Hazard
ratio
95%
Confidence limits
P
value
WRC (>0.9) REF REF REF REF
WRL (0.6-0.9) 1.015 0.934 1.103 .7273
WRVL (<0.6) 1.076 0.667 1.737 .7646
Ischemia time 1.077 1.039 1.117 <.0001
Recipient creatinine at
transplantation
1.1 1.069 1.131 <.0001
Male recipient 0.907 0.814 1.011 .0779
Recipient age 0.998 0.994 1.001 .1859
Donor age 1.017 1.012 1.021 <.0001
Recipient diabetes 1.09 0.963 1.233 .1711
Donor diabetes 0.998 0.762 1.306 .986
Pulmonary vascular resistance 1.031 1.01 1.053 .0041
Sex mismatch 1.191 1.03 1.377 .0183
Race mismatch 1.124 1.038 1.217 .004
HT, Heart transplantation; WRC, normal donor to recipient weight ratio;
REF, reference;WRL, donor to recipient body weight of 60% to 80%;WRVL, donor
to recipient body weight ratio of less than 60%.
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days on univariate survival analysis and a 20.1% increasedThe Journal of Thoracic and Carrisk for mortality after adjusting for pertinent clinical
factors on multivariate analysis. Previous studies have
demonstrated this finding.18,20 Patel and colleagues18
showed that underweight female donors have worse mortal-
ity when transplanting male recipients with an elevated
PVR. Further studies are needed to determine which
subgroups of recipients and donors have worse survival
when using underweight cardiac transplant donors. In this
study, we examined transplants that were performed with
a donor to recipient body weight ratio of less than 0.9 in
female donors to male recipients. We determined that
transplantation with female donor to male recipient weight
ratios of less than 0.9 is associated with greater mortality
risk than reduced median survival by longer than a year in
this study. Weight is the most commonly used metric to
match donors and recipients by size. However, other
factors, such as body mass index and height, might be better
standards for size matching potential donors to recipients.
Further studies are needed to determine the best method
of evaluating donor and recipient size matching.
Other factors associated with mortality on multivariate
analysis in the female donor to male recipient group were
longer ischemic time, increasing recipient serum creatinine
level, and increasing donor age. In the other group of
patients, increasing ischemic time, increasing recipient
serum creatinine level, race mismatch, sex mismatch, and
increasing donor age were associated with mortality, which
coincides with findings of other studies.7,8,18
This study had a few limitations, including those related
to retrospective analysis of large databases. All relevant
variables, such as socioeconomic status and immunosup-
pressive regimens, are not available in UNOS, which might
have a direct impact on survival. In addition, there is adiovascular Surgery c Volume 146, Number 6 1541
FIGURE 2. Kaplan-Meier survival analysis of female-to-male trans-
plantations, comparing control (>0.9) with low-weight ratio (0.6-0.9).
TABLE 3. Cox proportional hazards model for female-to-male HT
Predictors
Hazard
ratio
95%
Confidence limits
P
value
WRC (>0.9) REF REF REF REF
WRL (0.6-0.9) 1.208 1.01 1.444 .0383
WRVL (<0.6) 0.873 0.216 3.523 .8484
Ischemia time 1.127 1.04 1.221 .0035
Recipient creatinine at
transplantation
1.162 1.086 1.244 <.0001
Recipient age 0.996 0.988 1.003 .2801
Donor age 1.014 1.007 1.022 .0001
Recipient diabetes 1.29 0.979 1.699 .07
Donor diabetes 1.247 0.794 1.958 .3383
Pulmonary vascular resistance 1.006 0.959 1.055 .8054
Race mismatch 1.152 0.965 1.374 .1175
HT, Heart transplantation; WRC, normal donor to recipient weight ratio;
REF, reference;WRL, donor to recipient body weight of 60% to 80%;WRVL, donor
to recipient body weight ratio of less than 60%.
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donor echo findings, donor central venous pressure, and
descriptions of resuscitative efforts for the donor, are not
readily available in the database. Finally, because of
missing data, it was not feasible to include some variables
into the multiple regression models for survival analysis
and propensity matching. In addition, this analysis had a
small sample size at the very-low-weight ratio (<0.6),
thus limiting power in this subgroup analysis.
In conclusion, although the current International Society
of Heart and Lung Transplantation guidelines for weight
mismatch was shown to be safe in a study using a national
database, our study supports these findings and also shows
that extending donor weight mismatch criteria to a greater
degree (<40% mismatch for underweight donors) may be
safe in male to male, female to female, and male to female
heart transplants. In addition, our findings indicate that low
donor to recipient body weight ratios of less than 0.9 may1542 The Journal of Thoracic and Cardiovascular Surnot be acceptablewhen a female organ donor is transplanted
to a male recipient. Although this may hold for population-
based studies, decisions need to be made on a case-by-case
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